B
Beate I. Escher
Researcher at Helmholtz Centre for Environmental Research - UFZ
Publications - 337
Citations - 22520
Beate I. Escher is an academic researcher from Helmholtz Centre for Environmental Research - UFZ. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 74, co-authored 294 publications receiving 18425 citations. Previous affiliations of Beate I. Escher include Griffith University & University of Queensland.
Papers
More filters
Journal ArticleDOI
The Challenge of Micropollutants in Aquatic Systems
René P. Schwarzenbach,Beate I. Escher,Kathrin Fenner,Thomas B. Hofstetter,C. Annette Johnson,Urs von Gunten,Bernhard Wehrli +6 more
TL;DR: There are three scientific challenges in addressing water-quality problems caused by micropollutants, and usage and disposal strategies should aim to minimize introduction of critical pollutants into the aquatic environment.
Journal ArticleDOI
Modes of action in ecotoxicology: their role in body burdens, species sensitivity, QSARs, and mixture effects.
TL;DR: This review seeks to show the crucial role of target sites, interactions with the target site(s), and mechanisms for an adequate and efficient ecotoxicological risk assessment and recommends the use of internal effect concentrations and target site concentrations as a mixture toxicity parameter.
Journal ArticleDOI
Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater.
Beate I. Escher,Rebekka Baumgartner,M. Koller,Karin Treyer,Judit Lienert,Christa S. McArdell +5 more
TL;DR: In this article, the authors evaluated the ecotoxicological potential of the 100 pharmaceuticals expected to occur in highest quantities in the wastewater of a general hospital and a psychiatric center in Switzerland, and related the toxicity data to predicted concentrations in different wastewater streams to assess the overall risk potential for different scenarios, including conventional biological pretreatment in the hospital and urine source separation.
Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater
Beate I. Escher,Rebekka Baumgartner,M. Koller,Karin Treyer,Judit Lienert,Christa S. McArdell +5 more
TL;DR: Because high-risk pharmaceuticals are excreted mainly with feces, urine source separation is not a viable option for reducing the risk potential from hospital wastewater, while a sorption step could be beneficial.
Journal ArticleDOI
Benchmarking Organic Micropollutants in Wastewater, Recycled Water and Drinking Water with In Vitro Bioassays
Beate I. Escher,Mayumi Allinson,Mayumi Allinson,Rolf Altenburger,Peter A. Bain,Patrick Balaguer,Wibke Busch,Jordan Crago,Nancy D. Denslow,Elke Dopp,Klára Hilscherová,Andrew R. Humpage,Anu Kumar,Marina Grimaldi,B. Sumith Jayasinghe,Barbora Jarošová,Ai Jia,Sergei S. Makarov,Keith A. Maruya,Alexander V. Medvedev,Alvine C. Mehinto,Jamie E. Mendez,Anita H. Poulsen,Erik Prochazka,Jessica Richard,Andrea Schifferli,Daniel Schlenk,Stefan Scholz,Fujio Shiraishi,Shane A. Snyder,Guanyong Su,Janet Y. M. Tang,Bart van der Burg,Sander C. van der Linden,Inge Werner,Sandy D. Westerheide,Chris K C Wong,Min Yang,Bonnie H. Y. Yeung,Xiaowei Zhang,Frederic D.L. Leusch +40 more
TL;DR: This study has demonstrated that selected cell-based bioassays are suitable to benchmark water quality and it is recommended to use a purpose-tailored panel of bioassay for routine monitoring.